Novel thiophenecarboxamide IKK-2 inhibitors

被引:3
|
作者
不详
机构
关键词
asthma; chronic obstructive pulmonary disease (COPD); I kappa B kinase-2 (IKK-2); inflammation; rheumatoid arthritis; thiophene;
D O I
10.1517/13543776.15.3.343
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two applications claim novel ureido 5-(2-aminoethoxyphenyl)thiophenecarboxamide derivatives that differ in the position of the attached alkoxy chain, either ortho or para, as I kappa B kinase-2 (IKK-2) inhibitors. Some of the compounds display low nanomolar potency, and the compounds are claimed to be useful in the treatment of asthma, rheumatoid arthritis and chronic obstructive pulmonary disease (COPD).
引用
收藏
页码:343 / 347
页数:5
相关论文
共 50 条
  • [41] Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK
    Waelchli, R
    Bollbuck, B
    Bruns, C
    Buhl, T
    Eder, J
    Felfel, R
    Hersperger, R
    Janser, P
    Revesz, L
    Zerwes, HG
    Schlapbach, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (01) : 108 - 112
  • [42] The discovery of 2-amino-3,5-diarylbenzamide inhibitors of IKK-α and IKK-β kinases
    Christopher, John A.
    Avitabile, Barbara G.
    Bamborough, Paul
    Champigny, Aurelie C.
    Cutler, Geoffrey J.
    Dyos, Susan L.
    Grace, Ken G.
    Kerns, Jeffrey K.
    Kitson, Jeremy D.
    Mellor, Geoffrey W.
    Morey, James V.
    Morse, Mary A.
    O'Malley, Carolyn F.
    Patel, Champa B.
    Probst, Nicholas
    Rumsey, William
    Smith, Clive A.
    Wilson, Michael J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) : 3972 - 3977
  • [43] p38 MAPK, IKK-2 and Oxidative Stress Regulate Histone 3 Serine 10 Phosphorylation in Blood Monocytes and Alveolar Macrophages
    Marwick, J. A.
    Khorasani, N.
    Bhavsar, P.
    Adcock, I. M.
    Chung, K. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [44] Novel Tight-Binding Inhibitory Factor-κB Kinase (IKK-2) Inhibitors Demonstrate Target-Specific Anti-Inflammatory Activities in Cellular Assays and following Oral and Local Delivery in an in Vivo Model of Airway Inflammation
    Sommers, Cynthia D.
    Thompson, Janice M.
    Guzova, Julia A.
    Bonar, Sheri L.
    Rader, Randall K.
    Mathialagan, Sumathy
    Venkatraman, Neetu
    Holway, Vicky Walker
    Kahn, Larry E.
    Hu, George
    Garner, Debra S.
    Huang, Horng-Chih
    Chiang, Po-Chang
    Schindler, John F.
    Hu, Yiding
    Meyer, Debra M.
    Kishore, Nandini N.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (02): : 377 - 388
  • [45] T-lymphocyte-specific knockout of IKK-2 or NEMO induces Th17 cells in an experimental nephrotoxic nephritis mouse model
    Guo, Linlin
    Huang, Jiabin
    Chen, Meilan
    Piotrowski, Eveline
    Song, Ning
    Zahner, Gunther
    Paust, Hans-Joachim
    Alawi, Malik
    Geffers, Robert
    Thaiss, Friedrich
    FASEB JOURNAL, 2019, 33 (02): : 2359 - 2371
  • [46] Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
    Prescott, Jack A.
    Cook, Simon J.
    CELLS, 2018, 7 (09)
  • [47] IKK-2受体阻滞剂对角膜基质成纤维细胞的作用及机制
    仲炜
    姜宏
    赵婧
    中国组织工程研究, 2015, 19 (29) : 4688 - 4694
  • [48] A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hit
    Cushing, Timothy D.
    Baichwal, Vijay
    Berry, Karen
    Billedeau, Roland
    Bordunov, Viola
    Broka, Chris
    Cardozo, Mario
    Cheng, Peng
    Clark, David
    Dalrymple, Stacie
    DeGraffenreid, Michael
    Gill, Adrian
    Hao, Xiaolin
    Hawley, Ronald C.
    He, Xiao
    Jaen, Juan C.
    Labadie, Sharada S.
    Labelle, Marc
    Lehel, Csaba
    Lu, Pu-Ping
    McIntosh, Joel
    Miao, Shichang
    Parast, Camran
    Shin, Youngsook
    Sjogren, Eric B.
    Smith, Marie-Louise
    Talamas, Francisco X.
    Tonn, George
    Walker, Keith M.
    Walker, Nigel P. C.
    Wesche, Holger
    Whitehead, Chris
    Wright, Matt
    Browner, Michelle F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 417 - 422
  • [49] Synthesis and structure-activity relationships of novel IKK-β inhibitors.: Part 2:: Improvement of in vitro activity
    Murata, T
    Shimada, M
    Kadono, H
    Sakakibara, S
    Yoshino, T
    Masuda, T
    Shimazaki, M
    Shintani, T
    Fuchikami, K
    Bacon, KB
    Ziegelbauer, KB
    Lowinger, TB
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) : 4013 - 4017
  • [50] Evaluation of novel IKK-alpha inhibitors for the treatment of chronic lymphocytic leukaemia (CLL)
    Devi, Amarpreet
    O'Donnell, Alice
    Kennedy, Emma
    Clark, Heather
    Ammar, Usama
    Johnston, Rosalynd
    Mitchell, Simon
    Mackay, Simon
    Pepper, Chris
    Pepper, Andrea
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 63 - 64